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ABSTRACT
CONTEXT AND OBJECTIVE: Pre-eclampsia is a disorder that occurs only during pregnancy. Postpartum changes relating to lipid metabolism may 
contribute towards the endothelial lesions observed in preeclampsia. Thus, the aim of the present study was to evaluate the lipid profile among 
patients who present preeclampsia and correlate these parameters with 24-hour proteinuria. 
DESIGN AND SETTING: Cross-sectional analytical study including 77 pregnant patients seen at Hospital Dório Silva. 
METHODS: This study involved 42 women with preeclampsia and 35 healthy pregnant women in the third trimester of pregnancy as controls. Blood 
samples were obtained from all the patients, and the serum levels of triglycerides, total cholesterol, low-density lipoproteins (LDL), high-density 
lipoproteins (HDL) and very low density lipoproteins (VLDL) were determined. Cases and controls were matched for maternal age, gestational week 
and body mass index.  
RESULTS: The VLDL and triglyceride values from the women with preeclampsia were significantly higher than those of the healthy women. There was a 
positive correlation between increased proteinuria and higher VLDL and triglyceride levels in patients with preeclampsia. 
CONCLUSION: Among the patients with preeclampsia, higher VLDL and triglyceride levels were positively correlated with proteinuria. These observations 
indicate that the pregnant women who presented elevated lipid levels were more susceptible to cardiovascular disorders and, consequently, pre-
eclampsia. 
RESUMO 
CONTEXTO E OBJETIVO: A pré-eclâmpsia é um distúrbio que ocorre apenas durante a gravidez e as alterações pós-parto relacionadas ao metabolismo 
lipídico podem contribuir para a lesão endotelial observada nessa afecção. Assim, o objetivo do presente estudo foi avaliar o perfil lipídico em 
pacientes que apresentaram pré-eclâmpsia e correlacionar estes parâmetros com a proteinúria de 24 horas. 
TIPO DE ESTUDO E LOCAL: Estudo transversal analítico, incluindo 77 pacientes grávidas atendidas no Hospital Dório Silva.
MÉTODOS: Este estudo envolveu 42 mulheres com pré-eclâmpsia e 35 gestantes saudáveis no terceiro trimestre de gravidez como controle. 
Amostras de sangue foram obtidas de todas as pacientes e os níveis séricos de triglicérides, colesterol total, lipoproteínas de baixa densidade (LDL), 
lipoproteínas de alta densidade (HDL) e lipoproteínas de muito baixa densidade (VLDL) foram determinados. Casos e controles foram pareados por 
idade materna, semana gestacional e índice de massa corporal. 
RESULTADOS: Os valores de VLDL e triglicérides, obtidos de mulheres com pré-eclâmpsia foram significativamente maiores quando comparados com 
mulheres saudáveis. Houve uma correlação positiva entre o aumento da proteinúria e concentrações elevadas de VLDL e triglicérides, em pacientes 
com pré-eclâmpsia. 
CONCLUSÃO: Nas pacientes com pré-eclâmpsia foram observadas as maiores concentrações de VLDL e os níveis de triglicérides estão correlacionados 
positivamente com proteinúria. Estas observações indicam que as mulheres grávidas que apresentam níveis elevados de lipídios, são mais suscetíveis 
a doenças cardiovasculares e, consequentemente, a pré-eclâmpsia. 
KEY WORDS: 
Lipids.  
Hypertension, pregnancy-induced.  
Pre-eclampsia.  
Cholesterol. 
Hyperlipidemias.
PALAVRAS-CHAVE:  
Lipídeos.  
Hipertensão induzida pela gravidez. 
Pré-eclâmpsia. 
Colesterol. 
Hiperlipidemias.
INTRODUCTION
Pre-eclampsia is a disorder that occurs only during pregnancy 
and the postpartum period. It affects both the mother and the un-
born baby and occurs in approximately 5% of all pregnancies, be-
ing an important cause of maternal morbidity and mortality.1,2 De-
spite extensive investigations, important pathophysiological aspects 
of this disease remain unknown, thus delaying the development of 
preventive and therapeutic strategies.
This disorder is mediated by placental products that reach the 
maternal circulation and trigger endothelial dysfunction, thereby 
evoking cardiovascular diseases, such as vasospasm, increased en-
dothelial permeability and activation of thrombogenic mechanisms, 
and leading to the early events of atherosclerosis.3 Susceptibility to 
preeclampsia is also modulated by maternal factors, and women who 
present chronic hypertension, diabetes or hyperlipidemia are more 
likely to exhibit intense vascular reactivity, which evokes important 
disorders of physiological conditions.
Women with preeclampsia present arterial lesions at the uteropla-
cental implantation site. These morphological lesions are usually ob-
served in cases of acute atherosclerosis, and are characterized by areas 
with fibrinoid necrosis surrounded by lipid-laden macrophages.4
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These microscopic lesions are similar to atherosclerosis found out-
side pregnancy. Lipid deposits are also seen in the glomeruli of preec-
lamptic patients, a finding known as glomerular endotheliosis. Glom-
erular lesions are associated with proteinuria, a predictive indicator 
and marker of disease severity.3 It has also been suggested that low-
density lipoproteins (LDL)4 and triglycerides5-7 may be involved in 
this renal damage.
Furthermore, changes to lipid metabolism may contribute to-
wards the endothelial lesions observed in preeclampsia.8 The sever-
ity of both hypertension and proteinuria seems to reflect the degree 
of endothelial damage.9,10 The possible correlation between the altered 
lipid profile and the severity of renal lesions, as reflected by proteinu-
ria, may contribute towards clarify the complex pathophysiology of 
preeclampsia. 
OBJECTIVE
The aim of this study was to analyze the lipid profile among pa-
tients with preeclampsia, and compare it with that observed among 
healthy pregnant women. A second objective was to correlate these 
lipid profile findings among preeclamptic patients with the severity 
of proteinuria.
PATIENTS AND METHODS
Study design and size
We conducted a cross-sectional study that included 77 patients: 42 
women with preeclampsia and 35 healthy women. The patients were 
divided into two groups: pregnant women with preeclampsia (cases) 
and normal pregnant women (controls). The cases and controls were 
matched according to maternal age, gestational age, race and body 
mass index (BMI), in accordance with the selection criteria previously 
established. The study group and controls were selected from among 
the patients seen at Hospital Dória Silva, Vitória, Espírito Santo, Bra-
zil, between June 2005 and January 2008. The study was approved by 
the Ethics Committees of Hospital São Paulo, Universidade Federal 
de São Paulo — Escola Paulista de Medicina (Unifesp-EPM) number 
0188/05 and of Hospital Dória Silva, and written informed consent 
was obtained from all patients.
The sample size was calculated to compare two groups (cases and 
controls) with a 5% prevalence of preeclampsia, confidence level of 
95% and a power of 80%. In this case, it was expected that the maxi-
mum difference in proteinuria in the test group would be 30%, com-
pared with the unexposed group. Thus, the sample size would be a 
minimum of 33 women in each group. 
Measurements and lab tests
All the women seen at the hospital in the third trimester of sin-
gleton pregnancies were considered eligible for inclusion in the study. 
Gestational age was based on menstrual date and confirmed through 
ultrasound. Women with diabetes, chronic hypertension, autoimmune 
diseases or renal diseases were excluded. Preeclampsia was diagnosed 
in accordance with the criteria proposed by the National High Blood 
Pressure Education Program,10 i.e. blood pressure ≥ 140/90 mmHg 
and proteinuria ≥ 300 mg in 24 hour urine samples.
Blood samples were collected from all participants after a 12-
hour fast using 5 ml tubes containing ethylenediaminetetraacetic acid 
(EDTA). The samples were immediately centrifuged and processed us-
ing a lab test diagnostic kit. The serum levels of triglycerides, total cho-
lesterol, LDL, HDL and VLDL were interpreted in accordance with 
the recommendations of the National Cholesterol Education Program 
(Programa Nacional de Educação para o Colesterol, PNEC).11 Preec-
lamptic patients were then asked to collect urine for 24 hours for pro-
teinuria quantification. This was done by means of photometric read-
ings after addition of sulfosalicylic or trichloroacetic acid.
Statistical analysis
The mean serum lipid concentrations of the cases and controls 
were compared using Student’s t test. The mean level of each lipid 
was correlated with the 24 hour proteinuria concentration using Pear-
son’s coefficient test. Significance was set at P < 0.05. We also used the 
Student t test to compare the means of the groups for arterial pres-
sure, proteinuria, total cholesterol, high-density lipoproteins (HDL), 
LDL, very low density lipoproteins (VLDL) and triglycerides, taking 
P < 0.05. Correlations between proteinuria and cholesterol were made 
using Pearson’s correlation coefficient, considering only the group 
with preeclampsia. The analyses were performed using the EpiInfo 
software, version 6.
RESULTS
During the study period, 42 preeclamptic and 35 healthy pregnant 
women fulfilling the inclusion criteria were invited to participate in the 
study. The participants’ characteristics are presented in Table 1 and the 
data demonstrate that there were no significant differences in the wom-
en’s ages, extent of pregnancy, body mass index (BMI) or race. 
Furthermore, there were no significant differences in the total 
serum cholesterol, LDL and HDL levels between the preeclampsia 
cases and the healthy women. The preeclamptic patients had signifi-
cantly higher serum levels of triglycerides and VLDL, compared with 
the healthy controls (Table 2). The triglyceride and VLDL levels were 
positively and significantly correlated with the severity of proteinu-
ria (Table 2).
DISCUSSION
Hypertensive disorders during pregnancies, named preeclamp-
sia, are a pregnancy-specific disorder that affects 3-5%12,13 of pregnant 
women worldwide. Preeclampsia is one of the most frequently encoun-
tered medical complications of pregnancy. Classically, the condition 
presents with new-onset hypertension and proteinuria after 20 weeks 
of gestation.14 In developing countries where access to healthcare is 
limited, preeclampsia is a leading cause of maternal mortality, causing 
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an estimated 60,000 maternal deaths worldwide per year.12 Further-
more, preeclampsia is the third biggest cause of maternal mortality in 
the United States and accounts for 20% of maternal deaths.15
In Brazil, hypertension during pregnancy is the main cause of ma-
ternal death. Recent studies have pointed out that these hypertensive 
disorders are responsible for approximately 25% of deaths.16 Although 
manageable and preventable, these hypertensive disorders remain the 
leading cause of maternal death and a serious health problem that still 
affects a significant number of women.17 It is possible to infer that the 
determinants of maternal mortality due to hypertension during preg-
nancy are related to inadequate care and difficulties in accessing spe-
cialized reference services for high-risk pregnancy during the prenatal 
period, at childbirth and during the postpartum period, which would 
be able to provide better qualified and more efficient care.
The preeclamptic patients in our study presented significantly 
higher concentrations of triglycerides and VLDL than shown by the 
healthy women. In a review of 22 studies, Ray et al.18 reported that 
women with elevated triglycerides had twice the risk of preeclampsia, 
and the four studies that adjusted for confounders (age, BMI and pari-
ty) indicated that the risk was four times higher, compared with wom-
en with normal triglycerides. It was also suggested that triglyceride as-
sessment between 28 and 32 weeks could be predictive of preeclamp-
sia.19 Several other investigators have reported that hypertriglyceri-
demia could be involved in the pathogenesis of hypertensive disorders 
during pregnancy.19-23 In the present study, we also found a significant 
and positive association between proteinuria and both triglyceride and 
VLDL levels. These findings suggest that these lipids may be involved 
in the endothelial damage observed in our preeclampsia patients. 
Although it is still unclear whether hypertriglyceridemia becomes 
a risk factor for preeclampsia or whether there is any causal associa-
tion between them, high triglyceride levels seem to increase the risk of 
placental vascular disorders,19 which trigger endothelial dysfunction,24 
atherosclerosis and thrombosis.20 The development of atherosclerosis 
in the placental spiral arteries of preeclamptic women indicates that 
elevated levels of triglycerides are involved in this disorder.25
The fact that the patients with preeclampsia presented dyslipi-
demia, characterized by high levels of triglycerides and VLDL, indi-
cates that there are common interfaces between preeclampsia and the 
endothelial lesions that occur in atherosclerosis. Our results allow us to 
hypothesize that these lesions may evoke adverse cardiovascular events 
later on during the adulthood of these women. In a systematic review 
of the literature, Bellamy et al.26 reported that women with a history 
of preeclampsia presented increased risk of cardiovascular disease (risk 
relative, RR = 3.7), hypertension (RR = 2.16), ischemic heart attack 
(RR = 1.81), venous thromboembolism (RR = 1.79) and death (RR = 
1.49). These findings confirm the possible association between hyper-
tension during pregnancy and future cardiovascular disease. 
In order to implement preventive healthcare protocols, it is im-
portant to identify patients who are at risk of developing cardiovascu-
lar diseases. Better understanding of lipid metabolism abnormalities 
and of how these changes interact with the endothelial dysfunction of 
preeclampsia is crucial from a public health perspective. 
CONCLUSIONS
The findings reported in the present study corroborate the grow-
ing numbers of studies showing that women with preeclampsia pres-
ent lipid profile abnormalities and that these lipids become an in-
creased risk factor for cardiovascular complications. Therefore, these 
women should receive adequate counseling to urge them to adopt 
healthier habits and lifestyles and to seek periodic checkups, in order 
to detect cardiovascular disease in its early stages, before irreparable 
damage or even death ensues. 
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